Biotech · Private company
Histogen
Track this companyFree. Adds Histogen to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- EmricasanPhase 2 · CirrhosisClinicalTrials.gov · fetched Nov 12, 2026
- EmricasanPhase 1 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Hair Stimulating Complex (HSC)Phase 1 · AlopeciaClinicalTrials.gov · fetched Nov 12, 2026
- HST 001Phase 1 · Male Pattern Hair LossClinicalTrials.gov · fetched Nov 12, 2026
- microfracture surgery + HST003Phase 1 · Articular Cartilage Disorder of KneeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline CartilagePHASE1 · TERMINATED · started Nov 15, 2021ClinicalTrials.gov NCT05082831 · fetched Nov 12, 2026
- Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19PHASE1 · TERMINATED · started Mar 11, 2021ClinicalTrials.gov NCT04803227 · fetched Nov 12, 2026
- Safety and Efficacy of HST 001 in Male Pattern Hair LossPHASE1 · COMPLETED · started May 26, 2020ClinicalTrials.gov NCT04435847 · fetched Nov 12, 2026
- Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair LossPHASE1 · UNKNOWN · started Jul 2, 2018ClinicalTrials.gov NCT03662854 · fetched Nov 12, 2026
- Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal HypertensionPHASE2 · COMPLETED · started Oct 17, 2016ClinicalTrials.gov NCT02960204 · fetched Nov 12, 2026